Clinical Trials Browser

INDUSTRY × Neoplasm Metastasis × sotorasib × Clear all

NCT04892017 2025-10-10

A Phase 1/2 Study of Inlexisertib (DCC-3116) in Patients With RAS/MAPK Pathway Mutant Solid Tumors

Phase 1/2 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT05480865 2024-12-12

Argonaut

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis